Clinical characteristics of lung transplant (LT) recipients

Subjects n29
Age years48.7±13.6
Male sex n (%)14 (48)
Age at the time of LT years34.7±14.0
Years since LT14.0±3.1
BMI kg·m−221.6±5.6
FFMI kg·m−216.6±4.1
Haemoglobin g·dL−113.3±1.5
Arterial hypertension n (%)15 (51.7)
Diabetes mellitus n (%)6 (20.7)
Dyslipidaemia n (%)11 (37.9)
Smoking history n (%)
 Never smoked21 (72.4)
 Former smoker8 (27.6)
 Packs per year29.7±23.4
Lung function
 FVC L3.9±0.92
 FVC % predicted92.6±15.7
 FEV1 L3.1±0.7
 FEV1 % predicted97.9±14.5
DLCO (mL·mmHg−1·min−1) median (IQR)77.1 (70–83.3)
 TLC % predicted96.1±18.3
 RV % predicted81.0±8.5
Oral corticosteroids n (%)28 (96.6)
Oral corticosteroids dosage mg3.9±1.6

Data are presented as mean±sd, unless otherwise stated. Some variables have missing values: eight in FFMI, one in packs per year and one in corticosteroid dosage. ILD: interstitial lung disease; CF: cystic fibrosis; PH: pulmonary hypertension; BMI: body mass index; FFMI: fat-free mass index; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity of the lung for carbon monoxide; IQR: interquartile range; TLC: total lung capacity; RV: residual volume.